Croatia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Croatia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012 Add to your bookmarks!

$ 1 088 - May 2013 - by Business Monitor International - 104

Summary

Table of Contents

View Report

Search Inside

Data Series

Industry

Drug and Medication

Country

Croatia

Keywords

Patented Drug
Drug
Medicine

Companies

GlaxoSmithKline P.L.C.

Includes 3 FREE quarterly updates

Executive Summary
BMI View: Croatia's entrance into the EU will accelerate its economic liberalisation and the development
of the country's private sector. It is also likely to bring about an influx of EU funding in modernising the
country's economy. The Croatian pharmaceutical market continues to pose a challenging environment to
domestic and international drugmakers, but we believe EU accession will ease the regulatory burden as
legislation is harmonised with EU norms. In 2013 the economy is expected to post weak growth in
anticipation of capital inflows from the EU. However, the imposition of across the board price cuts later in
2013 will weigh heavily on the pharmaceutical market. We forecast weak pharmaceutical market growth for
the next decade due to the prevailing economic conditions in Europe. Healthcare spending is projected to
rise significantly over the next 10 years, in line with a rapidly ageing population.
Headline Expenditure Projections
• Pharmaceuticals: HRK7.50bn (US$1.28bn) in 2012 to HRK7.05bn (US$1.22bn) in 2013; -6% in local
currency and -5.1% in US dollar terms. Forecast changed from Q213, owing to price cuts
announcement from Health Ministry.
• Healthcare: HRK27.04bn (US$4.62bn) in 2012 to HRK28.27bn (US$4.88bn) in 2013; +4.5% in local
currency and 5.6% in US dollar terms. Forecast changed from Q213, owing to updated World Health
Organisation figures on government and private expenditure.

BMI Industry View 7
SWOT 9
Political 11
Economic 12
Business Environment 13
Industry Forecast 14
Pharmaceutical Market Forecast 14
Table: Croatia Pharmaceutical Sales, Historical Data And Forecasts, 2009-2017 15
Table: Reimbursed Drug Expenditure By HZZO (HRK) - Equivalent To Final Consumer Prices, 2008-2012 16
Healthcare Market Forecast 16
Table: Croatia Healthcare Expenditure Trends, Historical Data And Forecasts, 2009-2017 18
Table: Croatia Government Healthcare Expenditure Trends, Historical Data And Forecasts, 2009-2017 18
Table: Croatia Private Healthcare Expenditure Trends, Historical Data And Forecasts, 2009-2017 19
Prescription Drug Market Forecast 19
Table: Croatia Prescription Drug Market Indicators, Historical Data And Forecasts, 2009-2018 21
Patented Drug Market Forecast 21
Table: Croatia Patented Drug Market Indicators, Historical Data And Forecasts, 2009-2018 23
Generic Drug Market Forecast 23
Table: Croatia Generic Drug Market Indicators, Historical Data And Forecasts, 2009-2018 24
OTC Medicine Market Forecast 24
Table: Croatia Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts, 2009-2018 26
Pharmaceutical Trade Forecast 27
Table: Croatia Pharmaceutical Trade Data And Forecasts, 2009-2017 28
Table: Croatia Pharmaceutical Trade Data And Forecasts, 2009-2017 28
Other Healthcare Data 29
Key Risks To BMI's Forecast Scenario 29
Macroeconomic Forecasts 31
Economic Analysis 31
Risks To Outlook 36
Table: Croatia - Economic Activity 36
Industry Risk Reward Ratings 37
Central and Eastern Europe Risk/Reward Ratings 37
Croatia Risk/Reward Ratings 43
Rewards 43
Risks 44
Market Overview 46
Industry Trends And Developments 48
Epidemiology 48
Healthcare Provision 49
Healthcare Expenditure 49
Table: Reimbursed Drug Expenditure By HZZO - Equivalent to Final Consumer Prices, 2008-2012 50
Table: State Budget for Healthcare (HRKbn) 50
Healthcare Reform 51
Clinical Trials 52
Regulatory Development 54
Regulatory Regime 54
Pharmaceutical Advertising 56
Intellectual Property Regime 56
Pricing Regime 57
Reimbursement Regime 59
OTC Regulations 61
Competitive Landscape 63
Pharmaceutical Industry 63
Table: Top-10 Medicines By Value Sales 64
Domestic Pharmaceutical Industry 64
Table: Croatian Pharmaceutical Manufacturers 65
Foreign Pharmaceutical Industry 66
Company Activity 66
Pharmaceutical Wholesale 67
Pharmaceutical Retail 68
Company Profile 70
PLIVA 70
Belupo 74
Jadran Galenski Laboratorij 77
GlaxoSmithKline 80
Pfizer 83
Sanofi 85
Novartis 87
Merck & Co 89
Krka 91
Demographic Forecast 94
Table: Croatia's Population By Age Group, 1990-2020 ('000) 95
Table: Croatia's Population By Age Group, 1990-2020 (% of total) 96
Table: Croatia's Key Population Ratios, 1990-2020 97
Table: Croatia's Rural And Urban Population, 1990-2020 97
Glossary 98
Methodology 100
Pharmaceutical Expenditure Forecast Model 100
Healthcare Expenditure Forecast Model 100
Notes On Methodology 101
Risk/Reward Ratings Methodology 102
Ratings Overview 103
Table: Pharmaceutical Risk/Reward Ratings Indicators 103
Indicator Weightings 104

Drug and Medication in Croatia

Croatia Patented Drug Sales, Us$bn

$ 250
Industry data
January 2013

Yearly, From 2004 To 2021
By Business Monitor International
Source: WHO, BMI

Industries : Drug and Medication
Countries : Croatia

Croatia Patented Drug Sales, Us$bn, % Chg Y-o-y

$ 250
Industry data
January 2013

Yearly, From 2005 To 2021
By Business Monitor International
Source: WHO, BMI

Industries : Drug and Medication
Countries : Croatia

Croatia Patented Drug Sales, Us$bn, 5 Year Forward Cagr, %

$ 250
Industry data
January 2013

Yearly, From January 01, 2012 To January 01, 2012
By Business Monitor International
Source: WHO, BMI

Industries : Drug and Medication
Countries : Croatia

Croatia Patented Drug Sales, Us$bn, 5 Year Trailing Cagr, %

$ 250
Industry data
January 2013

Yearly, From January 01, 2012 To January 01, 2012
By Business Monitor International
Source: WHO, BMI

Industries : Drug and Medication
Countries : Croatia

Croatia Patented Drug Sales, Eurbn

$ 250
Industry data
January 2013

Yearly, From 2004 To 2021
By Business Monitor International
Source: WHO, BMI

Industries : Drug and Medication
Countries : Croatia

Drug And Medication Industry in Croatia : Latest Reports

Vaccines - Global Markets Package

$ 24 060
Industry report
May 2013
by Global Research & Data Services

This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different countries around the world. The studies provide essential market ...

Infertility Drugs And Devices Market - Global Industry Analysis, Size, Share And Forecast, 2010 - 2017

$ 4 395
Industry report
November 2013
by Transparency Market Research

This report is an effort to identify factors, which will be the driving force for the infertility drugs and devices market and sub-markets in the next few years. The report provides an extensive analysis ...

Triple Analysis: Angiogenesis, Cancer Vaccines and Peptides

$ 5 175
Industry report
March 2013
by Bioseeker

This triple analysis focuses on cancer drug development strategies by the two mechanism/target/effect areas of Angiogenesis and Cancer Vaccines and by the compound strategy of Peptides. Each of these three ...

Triple Analysis: Angiogenesis, Cancer Vacc ...

March 2013 $ 5 175

Triple Analysis: Angiogenesis, Cancer Vacc ...

March 2013 $ 5 175

Triple Analysis: Apoptosis, Angiogenesis A ...

March 2013 $ 5 175

Triple Analysis: Apoptosis, Cancer Vaccine ...

March 2013 $ 5 175

Triple Analysis: Apoptosis, Cancer Vaccine ...

March 2013 $ 5 175

Triple Analysis: Apoptosis, Cancer Vaccine ...

March 2013 $ 5 175

Triple Analysis: Breast Cancer, Angiogenes ...

March 2013 $ 5 175

Drug And Medication Industry in Croatia : Latest Downloads

Drug and Medication Industry Analysis

Industry report
April 2013
53 pages

... Use internally as part of a monthly cleansing regimen for gi health antibiotic, anti-inflammatory, antibacterial, antifungal, antioxidant, anti-parasitic, antiviral, disinfectant candida cleanse ...

Drug and Medication Market Brief

Industry report
April 2013
18 pages

... Antiosteoporosic drugs - casula m, filippi a, flacco e, gambera m, manzoli l, menditto e, orlando v, piccinelli r, tragni e, catapano a. Assessment and potential determinats of compliance and persistence to anti ...

Drug and Medication : Innovation and Technology Trends

Industry report
April 2013
12 pages

... Clinical regulatory toxicology phase i clinical phase ii clinical diabetes inflammation oncology (non-cytotoxic) anti-infectives clotting disorders obesity cns nce pipeline nce pipeline tyrosine-tzd, non ...